J. Sjef Verbeek

10.6k citations

129 papers · 7.9k indexed · 1 hit paper · h-index 52

Immunology top 0.2%
Radiology, Nuclear Medicine and Imaging top 0.2%
Molecular Biology top 2%
Oncology top 5%
Immunology and Allergy top 0.5%

Co-authors: Frans M.A. Hofhuis J. Engelbert Gessner Jan G. J. van de Winkel Ferry Ossendorp Reinhold Schmidt Takashi Saito Wouter L. W. Hazenbos P J Capel
Topics: Monoclonal and Polyclonal Antibodies Research (74 papers)T-cell and B-cell Immunology (41 papers)Glycosylation and Glycoproteins Research (24 papers)
Cited by: Immunology Immunology and Allergy Radiology, Nuclear Medicine and Imaging
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: Netherlands United States United Kingdom

In The Last Decade

J. Sjef Verbeek

129 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Arthritis Critically Dependent on Innate Immune System Players

2002 563 citations J. Sjef Verbeek et al. profile →

Peers

Countries citing papers authored by J. Sjef Verbeek

Since Specialization

Citations

This map shows the geographic impact of J. Sjef Verbeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Sjef Verbeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Sjef Verbeek more than expected).

Fields of papers citing papers by J. Sjef Verbeek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Sjef Verbeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Sjef Verbeek. The network helps show where J. Sjef Verbeek may publish in the future.

Co-authorship network of co-authors of J. Sjef Verbeek

This figure shows the co-authorship network connecting the top 25 collaborators of J. Sjef Verbeek. A scholar is included among the top collaborators of J. Sjef Verbeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Sjef Verbeek. J. Sjef Verbeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice 2021 ·Cancers ·Rens Braster,Marijn Bögels,(unknown),Manfred Wuhrer,Rosina Plomp,Arthur E. H. Bentlage,(unknown),Remco Visser,J. Sjef Verbeek,Marjolein van Egmond,Gestur Vidarsson	7
2	Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity 2020 ·Cancer Cell ·Xiaojie Yu,H.T. Claude Chan,(unknown),Christine A. Penfold,Jinny Kim,Tatyana Inzhelevskaya,C. Ian Mockridge,Ruth R. French,Patrick J. Duriez,Leon Douglas,(unknown),J. Sjef Verbeek,Ann L. White,Ivo Tews,Martin J. Glennie,Mark S. Cragg	48
3	Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment 2020 ·Scientific Reports ·(unknown),(unknown),Conny Brouwers,Margot M. Linssen,Marcel Camps,Cor Breukel,Jill Claassens,Thorbald van Hall,Ferry Ossendorp,Marieke F. Fransen,J. Sjef Verbeek	5
4	Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling 2019 ·Gut ·Pim J. Koelink,Felicia M. Bloemendaal,Bofeng Li,Liset Westera,Esther Vogels,Manon van Roest,(unknown),Angélique B. van ’t Wout,Hannelie Korf,Séverine Vermeire,Anje A. te Velde,Cyriel Y. Ponsioen,Geert D’Haens,J. Sjef Verbeek,Terrence L. Geiger,Manon E. Wildenberg,Gijs R. van den Brink	164
5	High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody Therapy 2018 ·The Journal of Immunology ·(unknown),(unknown),Cor Breukel,Jill Claassens,Conny Brouwers,Margot M. Linssen,Marieke F. Fransen,Marjolein Sluijter,Ferry Ossendorp,Thorbald van Hall,J. Sjef Verbeek	7
6	CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory 2018 ·Molecular Cancer Therapeutics ·(unknown),Işıl Altıntaş,Marjolein Sluijter,Sandra Verploegen,Aran F. Labrijn,Danita H. Schuurhuis,Mischa Houtkamp,J. Sjef Verbeek,Janine Schuurman,Thorbald van Hall	61
7	FcγRIIb on B Cells and Myeloid Cells Modulates B Cell Activation and Autoantibody Responses via Different but Synergistic Pathways in Lupus-Prone Yaa Mice 2018 ·The Journal of Immunology ·(unknown),Mareki Ohtsuji,Hirofumi Amano,Hiromichi Tsurui,Norihiro Tada,(unknown),Hidehiro Fukuyama,Hiroyuki Nishimura,J. Sjef Verbeek,Sachiko Hirose	3
8	Anti–Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis 2017 ·Gastroenterology ·Felicia M. Bloemendaal,Alon D. Levin,Manon E. Wildenberg,Pim J. Koelink,Bradford L. McRae,Jochen Salfeld,(unknown),Marijn van der Neut Kolfschoten,Jill Claassens,Remco Visser,Arthur E. H. Bentlage,Geert D’Haens,J. Sjef Verbeek,Gestur Vidarsson,Gijs R. van den Brink	27
9	IgG is elevated in obese white adipose tissue but does not induce glucose intolerance via Fcγ-receptor or complement 2017 ·International Journal of Obesity ·Anke Dam,Lianne van Beek,Amanda C. M. Pronk,Susan M. van den Berg,Jan Van den Bossche,Menno P.J. de Winther,Frits Koning,Cees van Kooten,Patrick C.N. Rensen,Mariëtte R. Boon,J. Sjef Verbeek,Ko Willems van Dijk,Vanessa van Harmelen	6
10	Antibodies Trap Tissue Migrating Helminth Larvae and Prevent Tissue Damage by Driving IL-4Rα-Independent Alternative Differentiation of Macrophages 2013 ·PLoS Pathogens ·Julia Esser‐von Bieren,Ilaria Mosconi,Romain Guiet,(unknown),(unknown),(unknown),William C. Gause,Arne Seitz,J. Sjef Verbeek,Nicola Harris	88
11	Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection 2010 ·Blood ·Stephen A. Beers,Ruth R. French,H.T. Claude Chan,Sean H. Lim,(unknown),(unknown),(unknown),Sandra V. Dixon,Hyungjin Kim,Kerry L. Cox,Jonathan P. Kerr,David A. Johnston,Peter Johnson,J. Sjef Verbeek,Martin J. Glennie,Mark S. Cragg	241
12	Fcγ Receptor I Alpha Chain (CD64) Expression in Macrophages Is Critical for the Onset of Meningitis by Escherichia coli K1 2010 ·PLoS Pathogens ·Rahul Mittal,Sunil K. Sukumaran,(unknown),(unknown),M. Madan Babu,Alan D. Schreiber,J. Sjef Verbeek,Nemani V. Prasadarao	34
13	Correction: Impaired Antibody Response Causes Persistence of Prototypic T Cell–Contained Virus 2009 ·PLoS Biology ·Andreas Bergthaler,Lukas Flatz,Admar Verschoor,Ahmed N. Hegazy,Martin Holdener,Katja Fink,Bruno Eschli,Doron Merkler,Rami Sommerstein,Edit Horváth,Marylise Fernandez,(unknown),Beatrice M. Senn,J. Sjef Verbeek,Bernhard Odermatt,Claire‐Anne Siegrist,Daniel D. Pinschewer	14
14	Both Complement and IgG Fc Receptors Are Required for Development of Attenuated Antiglomerular Basement Membrane Nephritis in Mice 2009 ·The Journal of Immunology ·Marielle A. Otten,Tom W.L. Groeneveld,Roelof Flierman,Maria Pia Rastaldi,Leendert A. Trouw,Maria C. Faber‐Krol,Annemieke Visser,(unknown),Jill Claassens,J. Sjef Verbeek,Cees van Kooten,Anja Roos,Mohamed R. Daha	37
15	Impact of a Three Amino Acid Deletion in the CH2 Domain of Murine IgG1 on Fc-Associated Effector Functions 2008 ·The Journal of Immunology ·Lucie Baudino,Falk Nimmerjahn,Yasuro Shinohara,Jun‐ichi Furukawa,Franz Petry,J. Sjef Verbeek,Shin‐Ichiro Nishimura,(unknown),Shozo Izui	14
16	Characterization of Antigen-Specific Immune Responses Induced by Canarypox Virus Vaccines 2007 ·The Journal of Immunology ·Rinke Bos,Suzanne van Duikeren,Thorbald van Hall,(unknown),Mark Parrington,Neil L. Berinstein,B. Kelly McNeil,Cornelis J.M. Melief,J. Sjef Verbeek,Sjoerd H. van der Burg,Rienk Offringa	19
17	C-Reactive Protein-Mediated Suppression of Nephrotoxic Nephritis: Role of Macrophages, Complement, and Fcγ Receptors 2007 ·The Journal of Immunology ·Wilfredo Rodriguez,Carolyn Mold,Milena Kataranovski,Julie A. Hutt,Lorraine L. Marnell,J. Sjef Verbeek,Terry W. Du Clos	51
18	Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine 2006 ·The Journal of Immunology ·Danita H. Schuurhuis,Nadine van Montfoort,Andreea Ioan‐Facsinay,(unknown),Marcel Camps,Jan Nouta,Cornelis J.M. Melief,J. Sjef Verbeek,Ferry Ossendorp	97
19	Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice 2003 ·The Journal of Immunology ·Eiríkur Saeland,Gestur Vidarsson,Jeanette H.W. Leusen,E. van Garderen,Moon H. Nahm,(unknown),Vanessa Walraven,Annette M. Stemerding,J. Sjef Verbeek,Ger T. Rijkers,Wietse Kuis,Elisabeth A. M. Sanders,Jan G. J. van de Winkel	65
20	A Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction 2000 ·The Journal of Immunology ·Ulrich Baumann,Jörg Köhl,Thomas Tschernig,(unknown),J. Sjef Verbeek,Reinhold Schmidt,J. Engelbert Gessner	98

About J. Sjef Verbeek

J. Sjef Verbeek is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 129 papers that have together received 7.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (74 papers), T-cell and B-cell Immunology (41 papers) and Glycosylation and Glycoproteins Research (24 papers). The work is most often cited by research in Immunology (4.8k citations), Immunology and Allergy (739 citations) and Radiology, Nuclear Medicine and Imaging (2.8k citations). J. Sjef Verbeek has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Frans M.A. Hofhuis, J. Engelbert Gessner, Jan G. J. van de Winkel, Ferry Ossendorp, Reinhold Schmidt, Takashi Saito, Wouter L. W. Hazenbos, P J Capel, Ingmar Heijnen and Dirk Meyer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact